RetinalGenix Technologies Inc. RTGN
$3.99
-$0.01-0.25%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 47.94% | 5.23% | -9.55% | 12.41% | -10.57% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | -14.29% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -49.33% | -15.94% | 0.90% | 6.50% | 4.61% |
| Change in Net Operating Assets | -119.11% | 121.01% | 119.35% | -76.94% | 4,380.95% |
| Cash from Operations | -25.18% | 14.82% | -23.51% | 25.38% | 25.69% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -2,329.03% | -93.82% | 43.84% |
| Total Debt Repaid | -19.41% | -- | -- | -- | -- |
| Issuance of Common Stock | 60.00% | -41.04% | 112.00% | 16.28% | -42.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 73.04% | -33.80% | 38.60% | -24.30% | -26.34% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 285.62% | -199.32% | 2,200.00% | 75.86% | -26.09% |